Clinical Trial Update: International Registry and Biorepository for TMA(Thrombotic Microangiopathy)

View source ↗

Summary

The international registry and biorepository study for thrombotic microangiopathy, including hemolytic uremic syndrome and thrombotic thrombocytopenic purpura, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemolytic Uremic Syndrome
• Thrombotic Microangiopathy
• Thrombotic Thrombocytopenic Purpura

Snippet

Sponsor: Northwell Health | Conditions: Thrombotic Microangiopathy, Hemolytic Uremic Syndrome | Status: TERMINATED